Showing results (121-130 of 636) with videos related to
Sort By:
Pageof 64
Cancer|August 15, 1993
Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogenH Matzkin, M S Soloway, P F Schellhammer, et al.The Journal of Urology|December 1, 1985
Major rectal complications following interstitial implantation of 125iodine for carcinoma of the prostateG H Jordan, D F Lynch, S S Warden, et al.The American Journal of Pathology|April 6, 2001
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urineA Vlahou, P F Schellhammer, S Mendrinos, et al.The Journal of Urology|May 1, 1987
Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapyP F Schellhammer, A M el-Mahdi, E M Higgins, et al.Cancer Research|November 1, 1983
Immunohistochemical localization of prostate carcinoma-associated antigensG L Wright, M L Beckett, J J Starling, et al.Clinical Chemistry|June 11, 1992
Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serumC L Huang, H M Liang, D Brassil, et al.Cancer Genetics and Cytogenetics|August 1, 1991
Cytogenetic evaluation of 20 cultured primary prostatic tumorsA R Brothman, D M Peehl, A M Patel, et al.Cancer Research|April 29, 2000
Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancerR P Ciavarra, K D Somers, R R Brown, et al.International Journal of Cancer|August 26, 1998
Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factorJ Gresham, P Margiotta, A J Palad, et al.The Prostate|February 15, 1997
Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRPW J Wasilenko, J Cooper, A J Palad, et al.Pageof 64